Journals / İstanbul Kuzey Klinikleri / 2021 / Cilt: 8 - Sayı: 5

Xanthogranulomatus inflammatory lesion mimicker of malignancy: A clinicopathological study from rural India

Pages
485–492
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, every excised specimen must be examined histopathologically to diagnose and rule out differential.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Xanthogranulomatus inflammation is an uncommon variant of chronic inflammation and a well-established pathological entity involving various organs and systems.
📊
Key Findings & Data:METHODS: This is a retrospective study conducted from January 2008 to April 2020 on histopathologically diagnosed xanthogranulomatus lesions.
💡
Conclusion & Impact:Thus, every excised specimen must be examined histopathologically to diagnose and rule out differential.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Xanthogranulomatus inflammation is an uncommon variant of chronic inflammation and a well-established pathological entity involving various organs and systems. It may be associated with infection and obstruction, defective lipid transport, immunological disturbances, and often confused as a malignant neoplasm. The confirmative diagnosis is made on histopathology. METHODS: This is a retrospective study conducted from January 2008 to April 2020 on histopathologically diagnosed xanthogranulomatus lesions. All the relevant available data regarding age, sex, and organ involvement were collected from histopathology lab records. The macroscopic and microscopic evaluation of cases was also done. This study was aimed to determine the significance of histopathology in the diagnosis of xanthogranulomatus lesions, revealing pathological changes, and clinicopathological correlation. RESULTS: In the current study, there were 93 cases of xanthogranulomatus inflammatory lesion. Gall bladder was frequently involved 70 (75.27%), followed by 5 (5.37%) kidney, gastrointestinal Tract 6 (3 [3.23%] cases in colon and 3 [3.23%] in appendix, respectively), and others. The maximum number of cases was in the age group of 31–40 years with 24 (25.80%) cases. The female to male sex ratio was 2.3:1. CONCLUSION: Awareness and knowledge of xanthogranulomatus inflammatory lesion is significant to the pathologist and surgeon to prevent extensive surgery. This lesion often mimics as malignancy and confirmatory diagnosis is made on histopathology. Thus, every excised specimen must be examined histopathologically to diagnose and rule out differential.

🔖

Cite This Article

Krishna, M., Dayal, S. (2022). Xanthogranulomatus inflammatory lesion mimicker of malignancy: A clinicopathological study from rural India. İstanbul Kuzey Klinikleri, Cilt: 8 - Sayı: 5, 485–492. https://ajindex.com/articles/652010

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Goodman ZD, Ishak KG. Xanthogranulomatous cholecystitis. Am J Surg Pathol 1981;5:653–9
  2. Lee HY, Kuo YT, Tsai SY, Li CC, Wu WJ, Huang CH, et al. Xanthogranulomatous prostatitis: a rare entity resembling prostate adenocarcinoma with magnetic resonance image picture. Clin Imaging 2012;36:858–60
  3. Kang TW, Lee KH, Piao CZ, Yun KJ, Joo HJ, Park KS, et al. Three cases of xanthogranulomatous epididymitis caused by E. coli. J Infect 2007;54:e69–73
  4. Nishimura M, Nishihira T, Hirose T, Ishikawa Y, Yamaoka R, Inoue H, et al. Xanthogranulomatous pancreatitis mimicking a malignant cystic tumor of the pancreas: report of a case. Surg Today 2011;41:1310–3
  5. Koo JS, Jung W. Xanthogranulomatous mastitis: clinicopathology and pathological implications. Pathol Int 2009;59:234–40
  6. Kuo TL, Cheng C. Xanthogranulomatous inflammation of urachus mimicking urachal carcinoma. Urology 2009;73:443.e13–4
  7. Antonakopoulos GN, Chapple CR, Newman J, Crocker J, Tudway DC, O’Brien JM, et al. Xanthogranulomatous pyelonephritis. A reappraisal and immunohistochemical study. Arch Pathol Lab Med 1988;112:275– 81
  8. Kansakar PB, Rodrigues G, Khan SA. Xanthogranulomatous cholecystitis: a clinicopathological study from a tertiary care health institution. Kathmandu Univ Med J (KUMJ) 2008;6:472–5
  9. Chuang YF, Cheng TI, Soong TC, Tsou MH. Xanthogranulomatous appendicitis. J Formos Med Assoc 2005;104:752–4
  10. Cozzutto C, Carbone A. The xanthogranulomatous process. Xanthogranulomatous inflammation. Pathol Res Pract 1988;183:395–402
  11. Rao RV, Kumar A, Sikora SS, Saxena R, Kapoor VK. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma. Trop Gastroenterol 2005;26:31–3
  12. Lopez JI, Elizalde JM, Calvo MA. Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases. Tumori 1991;77:358–60
  13. Laishram S, Shimray R, Pukhrambam GD, Sarangthem B, Sharma AB. Xanthogranulomatous inflammatory lesions: a 10-year clinicopathological study in a teaching hospital. Bangladesh Journal of Medical Science 2014;13:302–5
  14. Dixit VK, Prakash A, Gupta A, Pandey M, Gautam A, Kumar M, et al. Xanthogranulomatous cholecystitis. Dig Dis Sci 1998;43:940–2
  15. Roberts KM, Parsons MA. Xanthogranulomatous cholecystitis: clinicopathological study of 13 cases. J Clin Pathol 1987;40:412–7
  16. Chuang CK, Lai MK, Chang PL, Huang MH, Chu SH, Wu CJ, et al. Xanthogranulomatous pyelonephritis: experience in 36 cases. J